Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients
NCT02792335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28000
Last updated 2016-06-07
Summary
To describe the rate of discontinuation among Non-Valvular Atrial Fibrillation (NVAF) patients who were on warfarin and have switched to the Novel oral anticoagulants(NOACs).
Conditions
Interventions
- DRUG
-
apixaban
- DRUG
-
dabigatran
- DRUG
-
rivaroxaban
- DRUG
-
warfarin
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
More Related Trials
-
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
NCT04878497 ·Status: UNKNOWN
-
A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation
NCT00787150 ·Status: COMPLETED ·Phase: PHASE2
-
A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
NCT02591732 ·Status: COMPLETED
-
The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage
NCT02043808 ·Status: COMPLETED
-
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
NCT03926780 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
NCT04297150 ·Status: UNKNOWN
-
A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.
NCT03715725 ·Status: TERMINATED
-
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
NCT05038228 ·Status: ACTIVE_NOT_RECRUITING
-
The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage
NCT02061748 ·Status: COMPLETED
-
Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment
NCT04435769 ·Status: COMPLETED
-
Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
NCT02666157 ·Status: UNKNOWN ·Phase: PHASE4
-
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
NCT02090075 ·Status: COMPLETED ·Phase: PHASE4
-
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
NCT02283294 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
NCT02067182 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
NCT00448214 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study
NCT00252005 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers
NCT02559232 ·Status: COMPLETED
-
Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation
NCT06862726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction
NCT03359876 ·Status: COMPLETED
-
Anticoagulant Utilization Pattern
NCT01847560 ·Status: COMPLETED
-
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
NCT02889562 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea
NCT03572972 ·Status: COMPLETED
-
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
NCT03374540 ·Status: COMPLETED
-
A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
NCT03792152 ·Status: UNKNOWN ·Phase: NA
-
Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
NCT03490994 ·Status: UNKNOWN ·Phase: PHASE4